About: Unigene Laboratories     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FUnigene_Laboratories

Unigene Laboratories (OTC:UGNE) was a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey. The company's primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis. The company has licensed worldwide rights to its oral parathyroid hormone ("PTH") to GlaxoSmithKline.

AttributesValues
rdf:type
rdfs:label
  • Unigene Laboratories (en)
rdfs:comment
  • Unigene Laboratories (OTC:UGNE) was a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey. The company's primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis. The company has licensed worldwide rights to its oral parathyroid hormone ("PTH") to GlaxoSmithKline. (en)
foaf:name
  • Unigene Laboratories (en)
foaf:homepage
name
  • Unigene Laboratories (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
homepage
industry
key people
  • Jenene Thomas, Vice President, Investor Relations and Business Administration (en)
  • Ashleigh Palmer, President and CEO (en)
  • Roxanne Tavakkol, Vice President, Global Regulatory Affairs (en)
  • William Steinhauer, CPA Vice President, Finance (en)
  • Paul Shields, Ph.D., Vice President, Technology Transfer and Contract Manufacturing Services (en)
  • Gregory T. Mayes, Esq., Vice President, Corporate Development and General Counsel (en)
  • Nozer Mehta, Ph.D., Vice President, Biological Research and Development (en)
type
has abstract
  • Unigene Laboratories (OTC:UGNE) was a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey. The company's primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis. The company has licensed worldwide rights to its oral parathyroid hormone ("PTH") to GlaxoSmithKline. Unigene filed for Chapter 7 bankruptcy on July 2, 2013 in the United States Bankruptcy Court of the District of New Jersey. The Chapter 7 case is being administered under case No. 13-24696. (en)
gold:hypernym
dbp:wordnet_type
prov:wasDerivedFrom
page length (characters) of wiki page
industry
type
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 53 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software